期刊文献+

葛根素自微乳大鼠肠吸收的研究 被引量:3

Rat Intestinal Absorption of Puerarin Self-microemulsion
原文传递
导出
摘要 目的研究葛根素自微乳对大鼠肠吸收的改善作用。方法以离体大鼠外翻肠囊模型研究葛根素自微乳的肠吸收部位和促吸收效果,采用HPLC测定样品浓度,计算累计吸收率。结果葛根素自微乳在各肠段的累计吸收率比较依次为:回肠>空肠>十二指肠>结肠;葛根素自微乳的累计吸收率显著高于葛根素混悬液。结论葛根素自微乳最佳吸收部位为小肠中后段,尤其是回肠;与葛根素混悬液相比,葛根素自微乳能够显著改善肠吸收。 Objective To investigate rat intestinal absorption efficiency of puerarin self-microemulsion.Methods The isolated everted gut model was used to investigate the absorption sites and absorption efficiency of puerarin self-microemulsion in rats,the concentration of puerarin in the samples was detected by HPLC and its accumulative absorption rate was calculated.Results The accumulative absorption rate of puerarin self-microemulsion at different segments of rat intestine were as follows: ileum jejunum duodenum colon.The accumulative absorption rate of puerarin self-microemulsion was significantly improved compared with that of puerarin suspension.Conclusion The optimal absorption sites for puerarin self-microemulsion were in the middle and lower intestinal segments of rats,and ileum has the highest rate.The intestinal absorption of puerarin self-microemulsion is superior to that of puerarin suspension.
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2011年第2期181-184,共4页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 国家科技支撑计划项目(2006BA11B08-04)
关键词 葛根素 自微乳 外翻肠囊 肠吸收 Puerarin Self-microemulsion Isolated everted gut model Intestinal absorption
  • 相关文献

参考文献5

二级参考文献44

共引文献102

同被引文献48

  • 1张世忠,徐赫鸣,袁琨,杨星钢,雷杨,孙玉杰,潘卫三.星点设计-效应面法优化醋氯芬酸双层渗透泵控释片处方[J].中国药剂学杂志(网络版),2010(6):138-144. 被引量:6
  • 2杜志永,刘建平,朱家壁,谭力.丹参酮ⅡA固体脂质纳米粒的制备及大鼠在体肠吸收研究[J].中国药学杂志,2004,39(8):611-613. 被引量:25
  • 3姚静,卢韵,周建平,平其能.川陈皮素自微乳的制备及其大鼠在体肠吸收动力学[J].中国药科大学学报,2007,38(1):35-38. 被引量:28
  • 4苏艳丽,傅正义,马培艳,马晶晶,王为民.纳米化对三七中有效成分溶出的影响[J].中草药,2007,38(2):202-204. 被引量:3
  • 5FDA Center for Drug Evaluation and Research. Guidance for industry : waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system [EB/OL]. 2000-08 [ 2012-03-20]. http://www, fda. gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidanees/uem070246. pdf.
  • 6Zhao Chunjian, Wang Lei, Zu Yuangang, et al. Micronization of Ginkgo biloba extract using supercritical antisolvent process [J]. Powder Technology, 2011, 209 ( 1/3 ) :73.
  • 7Sun Z, Ma C H, Yang L, et al. Production of ursolic acid nanoparticles by supercritical antisolvent precipitation [J]. Adv Mater Res, 2011 (233/235) :2210.
  • 8Huh K M, Lee S C, Cho Y W, et al. Hydrotrop ic polymermicelle system for delivery of paclitaxel [ J ]. J Control Release, 2005, 101:5934.
  • 9Matsunaga N, Nakamura K, Yamamoto A, et al. Improvement by solid dispersion of the bioavailability of KRN633, a seleetive inhibitor of VEGF receptor tyrosine kinase, and identification of its potential therapeutic window[J]. Mol Cancer Ther, 2006, 5( 1 ):80.
  • 10Venkatramana M R, Erika A Z, Valentino J S. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent [ J ]. J Pharm Sci, 2011, 4(100) :1576.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部